1991
DOI: 10.1016/0016-5085(91)90711-s
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of enteral nutrition and drug treatment in active Crohn's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
94
2
8

Year Published

1997
1997
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 229 publications
(114 citation statements)
references
References 19 publications
10
94
2
8
Order By: Relevance
“…Peptamen received orally (0.5 mg/kg per day prednisolone) 10 (10) 2 wk Peptide group: CD activity score (CDAS): 5.6 ± 0.8 to 2 ± 1.4 (P < 0.01) ESR: 21.4 ± 6 to 16.7 ± 6.7 (P < 0.05) Permeability index: 4.9 ± 5.3 to 2.1 ± 2 (P < 0.01) BMI: 18.5 ± 3 to 19.2 ± 3.1 (P < 0.02) Prealbumin: 22.2 ± 8 to 23.5 ± 7.8 (P < 0.01) Retinol binding protein: 3.7 ± 0.7 to 4 ± 0.8 (P < 0.02) In vivo cell-mediated immunity (Multitest IMC): 4.2 ± 2.1 to 5.9 ± 2.3 (P < 0.01) (in the corticosteroid group, there were significant findings for improvement of simple CD activity index and fat free mass) [20] Adults with acute active CD…”
Section: Rctmentioning
confidence: 96%
See 1 more Smart Citation
“…Peptamen received orally (0.5 mg/kg per day prednisolone) 10 (10) 2 wk Peptide group: CD activity score (CDAS): 5.6 ± 0.8 to 2 ± 1.4 (P < 0.01) ESR: 21.4 ± 6 to 16.7 ± 6.7 (P < 0.05) Permeability index: 4.9 ± 5.3 to 2.1 ± 2 (P < 0.01) BMI: 18.5 ± 3 to 19.2 ± 3.1 (P < 0.02) Prealbumin: 22.2 ± 8 to 23.5 ± 7.8 (P < 0.01) Retinol binding protein: 3.7 ± 0.7 to 4 ± 0.8 (P < 0.02) In vivo cell-mediated immunity (Multitest IMC): 4.2 ± 2.1 to 5.9 ± 2.3 (P < 0.01) (in the corticosteroid group, there were significant findings for improvement of simple CD activity index and fat free mass) [20] Adults with acute active CD…”
Section: Rctmentioning
confidence: 96%
“…Studies of 100% WHP and Crohn's disease are characterized in Table 1 [5,10,11,[13][14][15][16][17][18][19][20][21][22][23][24][25] . In a one year prospective study, six Crohn's disease patients (median age, 13.6 years) were treated with an isotonic, 100% WHP semielemental diet to evaluate growth parameters and disease activity measures [11] .…”
Section: Crohn's Diseasementioning
confidence: 99%
“…Comparative studies have reported that steroids and sulfasalazine therapy are superior when compared to elemental diets 55,57 . Meta-analyses of randomized controlled trials also favor drug therapy over EN regarding remission of active CD in adults 22,34 .…”
Section: Enteral Nutrition (En)mentioning
confidence: 99%
“…83,85,88 In two others, the conclusion that the two treatments were therapeutically equivalent was made only after any individuals who were unable to tolerate the enteral feedings (and who may have had more severe disease) were excluded from the analysis. 82,86 The two largest trials 92,93 found that the steroid therapy was superior to the enteral feeding. Two meta-analyses have also concluded that steroid therapy is superior.…”
Section: In¯ammatory Bowel Diseasementioning
confidence: 99%